Cambridge Major Labs names new president and CEO
Brian Scanlan has been promoted to president and chief executive officer of Germantown-based Cambridge Major Laboratories Inc., a developer and manufacturer of active pharmaceutical ingredients (APIs). APIs are the active ingredients in prescription drugs.
Dr. Michael Major, the company’s founder and CEO, will retire. Major will remain non-executive chairman and scientific advisor to the company.
Scanlan joined CML in 2002, and worked previously as its chief business officer. He has been an active member of the Company’s board of directors the past four years. In his new role, he will have responsibility for all of CML’s operations in the US and Europe.
“I want to express my sincere thanks to all of the past and present employees of the Company, for their commitment and help in achieving this unprecedented growth,” Major said. “The company grew from a small research lab to a highly sophisticated API manufacturing organization, and now requires a new talent to bring it to the next level. Brian is uniquely qualified, and I am convinced that Brian will fulfill all of the expectations. I wish him a lot of success.”
“I look forward to leading CML into the future,” said Scanlan. “It has been an honor to work alongside Michael these past nine years. He is one of the most gifted entrepreneurs I have ever met. I will ensure that CML continues its long-standing reputation for technical excellence, service, and responsiveness. We will continue to invest in the best people and cutting edge technologies to stay ahead of our competition, and better serve our customers.”
